These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24072672)
1. Unexpected Properties of δ-Containing GABAA Receptors in Response to Ligands Interacting with the α+ β- Site. Mirheydari P; Ramerstorfer J; Varagic Z; Scholze P; Wimmer L; Mihovilovic MM; Sieghart W; Ernst M Neurochem Res; 2014 Jun; 39(6):1057-1067. PubMed ID: 24072672 [TBL] [Abstract][Full Text] [Related]
2. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors. Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935 [TBL] [Abstract][Full Text] [Related]
3. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors. Feng HJ; Jounaidi Y; Haburcak M; Yang X; Forman SA Br J Pharmacol; 2014 Feb; 171(3):789-98. PubMed ID: 24199598 [TBL] [Abstract][Full Text] [Related]
4. The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs. Ramerstorfer J; Furtmüller R; Sarto-Jackson I; Varagic Z; Sieghart W; Ernst M J Neurosci; 2011 Jan; 31(3):870-7. PubMed ID: 21248110 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface. Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852 [TBL] [Abstract][Full Text] [Related]
6. Alcohol selectivity of β3-containing GABAA receptors: evidence for a unique extracellular alcohol/imidazobenzodiazepine Ro15-4513 binding site at the α+β- subunit interface in αβ3δ GABAA receptors. Wallner M; Hanchar HJ; Olsen RW Neurochem Res; 2014 Jun; 39(6):1118-26. PubMed ID: 24500446 [TBL] [Abstract][Full Text] [Related]
7. Comparison of αβδ and αβγ GABA Feng HJ; Forman SA Pharmacol Res; 2018 Jul; 133():289-300. PubMed ID: 29294355 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. Stórustovu SI; Ebert B J Pharmacol Exp Ther; 2006 Mar; 316(3):1351-9. PubMed ID: 16272218 [TBL] [Abstract][Full Text] [Related]
10. A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface. Sieghart W; Ramerstorfer J; Sarto-Jackson I; Varagic Z; Ernst M Br J Pharmacol; 2012 May; 166(2):476-85. PubMed ID: 22074382 [TBL] [Abstract][Full Text] [Related]
12. Molecular mode of action of CGS 9895 at α1 β2 γ2 GABAA receptors. Maldifassi MC; Baur R; Sigel E J Neurochem; 2016 Sep; 138(5):722-30. PubMed ID: 27319298 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. Whittemore ER; Yang W; Drewe JA; Woodward RM Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369 [TBL] [Abstract][Full Text] [Related]
14. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Pistis M; Belelli D; Peters JA; Lambert JJ Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818 [TBL] [Abstract][Full Text] [Related]
15. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies. Huh KH; Delorey TM; Endo S; Olsen RW Mol Pharmacol; 1995 Oct; 48(4):666-75. PubMed ID: 7476892 [TBL] [Abstract][Full Text] [Related]
17. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619 [TBL] [Abstract][Full Text] [Related]
18. Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Savić MM; Majumder S; Huang S; Edwankar RV; Furtmüller R; Joksimović S; Clayton T; Ramerstorfer J; Milinković MM; Roth BL; Sieghart W; Cook JM Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):376-86. PubMed ID: 20074611 [TBL] [Abstract][Full Text] [Related]
19. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs. Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789 [TBL] [Abstract][Full Text] [Related]